bioRxivBiochemistryPreprint
Crystallographic fragment screen of Enterovirus D68 3C protease and iterative design of lead-like compounds using structure-guided expansions
Ryan M. LithgoiD, Charles W.E. TomlinsoniD, M. FairheadiD, Max WinokaniD, Warren Athol ThompsoniD, Conor Francis WildiD, Jasmin Cara AschenbrenneriD, Blake H. BalcombiD, Peter George MarplesiD, Anu V. ChandraniD, Mathew GoldingiD, L. KoekemoeriD, Eleanor WilliamsiD, SiYl Wang, Xiaomin NiiD, Elizabeth MacLeaniD, Charline GiroudiD, Tryfon Zarganes‐TzitzikasiD, Andre Schutzer GodoyiD, Mary-Ann Elvina XavieriD, Martin Austin WalshiD, D. FearoniD, F. von DelftiD
Abstract
The development of effective broad-spectrum antivirals forms an important part of preparing for future pandemics. One cause for concern is the currently emerging pathogen Enterovirus D68 (EV-D68) which primarily spreads through respiratory routes causing mostly mild to severe respiratory illness but, in severe cases, acute flaccid myelitis. The 3C protease of EV-D68 (3Cpro) is a potential target for the development of antiviral drugs due to its essential role in the viral life cycle and high sequence conservation amongst family members. In this study, we describe the identification of fragments which bind to3Cpro using crystallographic screening and the expansion of these into more lead-like compounds. The hits revealed interesting directions for hit-to-lead progression, specifically the importance of the pocket occupied by the conserved glutamine sidechain of the substrates and the interactions formed. Additionally, two pockets could be joined by not following the backbone of the native substrates, thus circumventing the screening issues arising from the flexibility of the catalytic triad. These observations of the novel binding modes of the chemical matter found by this screen can help shape future drug design campaigns against 3C proteases.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening
Iman Biswas, Qinghui Wang, … Francesc X. Ruiz·bioRxiv·Jul 10, 2026
- Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enterovirals
Ryan M. Lithgo, Charles W.E. Tomlinson, … F. von Delft·bioRxiv·Apr 29, 2024
- Acrylamide Fragment Inhibitors that Induce Unprecedented Conformational Distortions in Enterovirus 71 3C and SARS-CoV-2 Main Protease
B. Qin, G. B. Craven, … S. Cui·bioRxiv·Nov 6, 2020
- Differential Inhibition of Intra- and Inter-molecular Protease Cleavages by Antiviral Compounds
J. S. Doherty, K. Kirkegaard·bioRxiv·Jun 28, 2023
- Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals
David L. Cousins, Ed Griffen, … Kris M. White·bioRxiv·Aug 8, 2025
- A molecular dynamic investigation of Human Rhinovirus 3C Protease Drug Target: Insights towards the design of potential Inhibitors
Ndumiso M. Buthelezi, Daniel Gyamfi Amoako, … Hezekiel Mathambo Kumalo·bioRxiv·Mar 6, 2022